Literature DB >> 34301158

Molecular docking and dynamics study to explore phytochemical ligand molecules against the main protease of SARS-CoV-2 from extensive phytochemical datasets.

Shafi Mahmud1, Mohasana Akter Mita2, Suvro Biswas2, Gobindo Kumar Paul1, Maria Meha Promi2, Shamima Afrose2, Robiul Hasan2, Sharmin Sultana Shimu2, Shahriar Zaman1, Salah Uddin1, Trina Ekawati Tallei3, Talha Bin Emran4, Abu Saleh1.   

Abstract

BACKGROUND: The high transmission and pathogenicity of SARS-CoV-2 has led to a pandemic that has halted the world's economy and health. The newly evolved strains and scarcity of vaccines has worsened the situation. The main protease (Mpro) of SARS-CoV-2 can act as a potential target due to its role in viral replication and conservation level.
METHODS: In this study, we have enlisted more than 1100 phytochemicals from Asian plants based on deep literature mining. The compounds library was screened against the Mpro of SARS-CoV-2.
RESULTS: The selected three ligands, Flemichin, Delta-Oleanolic acid, and Emodin 1-O-beta-D-glucoside had a binding energy of -8.9, -8.9, -8.7 KJ/mol respectively. The compounds bind to the active groove of the main protease at; Cys145, Glu166, His41, Met49, Pro168, Met165, Gln189. The multiple descriptors from the simulation study; root mean square deviation, root mean square fluctuation, radius of gyration, hydrogen bond, solvent accessible surface area confirms the stable nature of the protein-ligand complexes. Furthermore, post-md analysis confirms the rigidness in the docked poses over the simulation trajectories.
CONCLUSIONS: Our combinatorial drug design approaches may help researchers to identify suitable drug candidates against SARS-CoV-2.

Entities:  

Keywords:  SARS-CoV-2; admet; molecular docking; molecular dynamics; phytochemicals

Mesh:

Substances:

Year:  2021        PMID: 34301158     DOI: 10.1080/17512433.2021.1959318

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  17 in total

Review 1.  Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature's toolbox of bioactive compounds.

Authors:  Io Antonopoulou; Eleftheria Sapountzaki; Ulrika Rova; Paul Christakopoulos
Journal:  Comput Struct Biotechnol J       Date:  2022-03-14       Impact factor: 7.271

2.  Natural flavonoids effectively block the CD81 receptor of hepatocytes and inhibit HCV infection: a computational drug development approach.

Authors:  Dipta Dey; Partha Biswas; Priyanka Paul; Shafi Mahmud; Tanzila Ismail Ema; Arysha Alif Khan; Shahlaa Zernaz Ahmed; Mohammad Mehedi Hasan; Abu Saim Mohammad Saikat; Babry Fatema; Shabana Bibi; Md Ataur Rahman; Bonglee Kim
Journal:  Mol Divers       Date:  2022-07-12       Impact factor: 3.364

Review 3.  Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2.

Authors:  Kaifu Gao; Rui Wang; Jiahui Chen; Limei Cheng; Jaclyn Frishcosy; Yuta Huzumi; Yuchi Qiu; Tom Schluckbier; Xiaoqi Wei; Guo-Wei Wei
Journal:  Chem Rev       Date:  2022-05-20       Impact factor: 72.087

4.  Modeling Kaempferol as a Potential Pharmacological Agent for COVID-19/PF Co-Occurrence Based on Bioinformatics and System Pharmacological Tools.

Authors:  Yong Jiang; Yi-Zi Xie; Chen-Wen Peng; Kai-Nan Yao; Xue-Ying Lin; Shao-Feng Zhan; Hong-Fa Zhuang; Hui-Ting Huang; Xiao-Hong Liu; Xiu-Fang Huang; Hang Li
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

5.  Synthesis, antimicrobial, molecular docking and molecular dynamics studies of lauroyl thymidine analogs against SARS-CoV-2: POM study and identification of the pharmacophore sites.

Authors:  Mohammed Anowar Hosen; Nasrin Sultana Munia; Mohammed Al-Ghorbani; Mohammed Baashen; Faisal A Almalki; Taibi Ben Hadda; Ferdausi Ali; Shafi Mahmud; Md Abu Saleh; Hamid Laaroussi; Sarkar M A Kawsar
Journal:  Bioorg Chem       Date:  2022-05-04       Impact factor: 5.307

6.  Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations.

Authors:  Md R Amin; Farhana Yasmin; Sujan Dey; Shafi Mahmud; Md A Saleh; Talha B Emran; Imtiaj Hasan; Sultana Rajia; Yukiko Ogawa; Yuki Fujii; Masao Yamada; Yasuhiro Ozeki; Sarkar M A Kawsar
Journal:  Glycoconj J       Date:  2022-01-17       Impact factor: 3.009

7.  Biochemical and Molecular Dynamics Study of a Novel GH 43 α-l-Arabinofuranosidase/β-Xylosidase From Caldicellulosiruptor saccharolyticus DSM8903.

Authors:  Md Abu Saleh; Shafi Mahmud; Sarah Albogami; Ahmed M El-Shehawi; Gobindo Kumar Paul; Shirmin Islam; Amit Kumar Dutta; Md Salah Uddin; Shahriar Zaman
Journal:  Front Bioeng Biotechnol       Date:  2022-02-11

8.  Computational screening and biochemical analysis of Pistacia integerrima and Pandanus odorifer plants to find effective inhibitors against Receptor-Binding domain (RBD) of the spike protein of SARS-Cov-2.

Authors:  Gobindo Kumar Paul; Shafi Mahmud; Afaf A Aldahish; Mirola Afroze; Suvro Biswas; Swagota Briti Ray Gupta; Mahmudul Hasan Razu; Shahriar Zaman; Md Salah Uddin; Mohammed H Nahari; Mohammed Merae Alshahrani; Mohammed Abdul Rahman Alshahrani; Mala Khan; Md Abu Saleh
Journal:  Arab J Chem       Date:  2021-12-01       Impact factor: 5.165

9.  Identification of phytochemical inhibitors of SARS-CoV-2 protease 3CLpro from selected medicinal plants as per molecular docking, bond energies and amino acid binding energies.

Authors:  Sami Ullah; Bushra Munir; Abdullah G Al-Sehemi; Shabbir Muhammad; Ikram-Ul Haq; Abida Aziz; Bilal Ahmed; Abdul Ghaffar
Journal:  Saudi J Biol Sci       Date:  2022-03-24       Impact factor: 4.052

10.  Appraisal of Bioactive Compounds of Betel Fruit as Antimalarial Agents by Targeting Plasmepsin 1 and 2: A Computational Approach.

Authors:  Trina Ekawati Tallei; Billy Johnson Kepel; Mohammed Alorabi; Ahmed M El-Shehawi; Widdhi Bodhi; Sefren Geiner Tumilaar; Ismail Celik; Gomaa Mostafa-Hedeab; Amany Abdel-Rahman Mohamed; Talha Bin Emran
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.